Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (Diluted Average): 2023-2025

Historic Shares Outstanding (Diluted Average) for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $8.9 million.

  • Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) rose 1323.84% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 1323.84%. This contributed to the annual value of $736,339 for FY2024, which is 9191.34% up from last year.
  • Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) amounted to $8.9 million in Q3 2025, which was up 21.78% from $7.3 million recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) peaked at $10.3 million during Q1 2023, and registered a low of $7,925 during Q4 2023.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) had a median value of $724,190 in 2023 and averaged $3.2 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first plummeted by 99.73% in 2024, then soared by 21,155.22% in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) (Quarterly) stood at $7,925 in 2023, then spiked by 9,191.34% to $736,339 in 2024, then skyrocketed by 1,323.84% to $8.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $8.9 million for Q3 2025, versus $7.3 million for Q2 2025 and $5.9 million for Q1 2025.